NCT04432597 HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04357873 Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations Status COMPLETED Phase PHASE2
NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04234113 Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT04230759 Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04157985 Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors Status COMPLETED Phase PHASE3
NCT04141449 A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04094454 Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy Status RECRUITING Phase NA
NCT04028479 The Registry of Oncology Outcomes Associated with Testing and Treatment Status COMPLETED Phase N/A
NCT03983174 Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula Status COMPLETED Phase NA
NCT03947775 HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL Status NOT_YET_RECRUITING Phase PHASE2
NCT03856437 A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination Status COMPLETED Phase NA
NCT03792854 Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE) Status RECRUITING Phase N/A
NCT03677960 Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection Status TERMINATED Phase PHASE1
NCT03519295 A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma Status COMPLETED Phase PHASE2
NCT03506529 Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT Status COMPLETED Phase N/A